Tuesday, June 10, 2008

Chromium supplement offers diabetes hope

DIABETIC STATISTICS
An estimated 19 million people are affected by diabetes in the EU, equal to four per cent of the total population. This figure is projected to increase to 26 million by 2030.

In the US, there are over 20 million people with diabetes, equal to seven per cent of the population. The total costs are thought to be as much as $132 billion, with $92 billion being direct costs from medication, according to 2002 American Diabetes Association figures.

CHROMIUM REQUIREMENT
Researchers have reported how chromium (one of the component in GTF) improves muscle sensitivity to insulin in obese, insulin-resistant rats - findings that could have implications for diabetic humans.
Insulin resistance occurs when muscle and fat tissue, for example, react poorly to insulin, the hormone responsible for glucose metabolism. The condition is found in both pre-diabetics and those with fully developed diabetes.

Previous research has shown that chromium supplements could enhance insulin sensitivity by improving receptor signalling, but these had been limited to in vitro studies.

The new study, published in the Journal of Nutrition (Vol 136, pp. 415-420), is the first to use in vivo animal models to demonstrate the mechanism.

Also, The Clinical Test has been published in Journal Metabolism Clinical & Experimental Vol. 55 (2006) Pg. 923-927

Title: The influence of chromium chloride–containing milk to glycemic control of patients with type 2 diabetes mellitus: a randomized, double-blind, placebo-controlled trial.

~END

No comments:

YOU CAN GET GTF SUPPLEMENT THROUGH THIS FOLLOWING AGENT: